The transport of the anti-varicella-zoster virus agent 6-methoxypurine arabinoside and its 2'-O-valerate prodrug, 170U88, was investigated by using the human erythrocyte model. The influx of 6-methoxypurine arabinoside was found to occur primarily by means of the nucleoside transporter. (i) Influx was nonconcentrative and saturable (Km = 106 ± 2 I,M). (ii) The inhibitors of nucleoside transport, nitrobenzylthioinosine, dipyridamole, and dilazep, inhibited the influx of 10 ,iM 6-methoxypurine arabinoside by >94%. (iii) Influx was inhibited by nucleosides but not by nucleobases. (iv) 6-Methoxypurine arabinoside was a competitive inhibitor (Ki = 129 ± 10 ,uM) of adenosine influx, and adenosine (Km = 160 ± 9 ,uM) was found to be a competitive inhibitor (Ki = 134 ± 9 ,uM) of 6-methoxypurine arabinoside influx. By contrast, the influx of 170U88 occurred by means of nonfacilitated diffusion. (i) Influx was linearly dependent on the 170U88 concentration. (ii) Influx was not inhibited by nucleobases, nucleosides, or inhibitors of nucleoside transport.
The transport of arabinosides into human cells has received relatively little attention. Cytosine arabinoside transport into human T lymphoblasts, normal lymphocytes, and neutrophils proceeds primarily by means of the nitrobenzylthioinosine (NBMPR)-sensitive nucleoside transport system and, secondarily (11 to 22%), by nonfacilitated diffusion, a process which becomes more important at higher cytosine arabinoside concentrations (20) . Arabinosides of adenine (3) (4) (5) and guanine (17) enter human erythrocytes chiefly by means of the NBMPR-sensitive nucleoside transporter. 6-Methoxypurine arabinoside [6-methoxy-9 -(P-D-arabinofuranosyl)-9H-purine; ara-M] is a novel antiviral agent with potent and selective activity against varicella-zoster virus (2) . Esterification of ara-M at the 2' position reduced its catabolism by adenosine deaminase when ara-M was administered orally, thereby improving its pharmacokinetic profile (18) . The transport properties of ester prodrugs of nucleoside analogs with respect to human cells have not heretofore been documented. This report describes the mechanism of transport of ara-M and its 2'-O-valerate prodrug, 6-methoxy- isolated by centrifugation as described previously (23) . Physiological saline containing 10 mM HEPES (pH 7.3) was used as the medium. The cell concentration was checked with a hematocrit centrifuge, and the final cell suspension was adjusted to 10% hematocrit.
Kinetics of nucleoside influx into erythrocytes. The influx of [3H]ara-M or ['4C]170U88 was measured by determination of the intracellular radioactivity at appropriate times after the addition of 50 ,ul of radiolabeled permeant to 50 RI of erythrocyte suspension. After termination of the reaction by the addition of 700 ,ul of ice-cold 20 mM papaverine (10), cell suspensions were centrifuged through n-butylphthalate and the cell pellets were processed as described previously (23) . The use of papaverine as an agent to stop the reaction was validated for each permeant by monitoring the influx of labeled permeant with time after the addition of papaverine and by comparison of zero time assays with the extracellular volume, as determined with ['4C]sucrose (10) . The purity of radiolabeled permeants was assessed by reversed-phase high-pressure liquid chromatography (24 matography (24) . Because of concern regarding the acid stability of 170U88, erythrocytes incubated with 0.55 mM [14C]170U88 were extracted with ice-cold acetonitrile (1) and evaporated to dryness under a filtered stream of nitrogen. Samples were reconstituted with 25 mM ammonium phosphate (pH 7.2) and analyzed by reversed-phase high-pressure liquid chromatography (24) by using an acetonitrile gradient buffered with ammonium phosphate (pH 7.2).
RESULTS
Time dependence of influx. The influx of 12.5 F.M ara-M at 37°C was linear up to 1.5 s, and equilibrium was reached in 20 s (Fig. 1) , whereupon the intracellular concentration of ara-M was approximately equal to the extracellular concentration. The initial influx rate of 170U88 was too rapid at 37°C to determine accurately. Therefore, 170U88 influx was monitored at 20°C and was found to be linear for up to 1.5 s. Equilibrium was reached in 5 min with 150 FM 170U88 (Fig.  2) .
Concentration dependence of influx. The influx of ara-M into human erythrocytes at 37°C appeared to be a saturable process, with a Km of 106 ± 2 ,uM (n = 5; The rate constant, in the absence and presence of NBMPR, was 0.35 pmol/s/,uM/10 p.l of packed cells at 20°C.
Kinetic analysis of ara-M influx. ara-M was found to be a competitive inhibitor (Ki = 129 + 10 ,uM; n = 2) of adenosine influx (Fig. 5) . Conversely, adenosine (Km = 160 ± 9 F.M; n = 2) was found to be a competitive inhibitor (Ki = 134 + 9 p.M; n = 2) of ara-M influx (Fig. 6) . These experiments were performed in the presence of 1.0 p.M deoxycoformycin and 0.1 p.M 5-iodotubercidin to eliminate the metabolism of adenosine. Effect of nucleosides, nucleobases, and inhibitors of nucleoside transport. Inosine and uridine (1 mM) inhibited the influx of 10 p.M ara-M by 75 and 64%, respectively, whereas adenine or hypoxanthine, at the same concentration, had no effect (Table 1 ). In contrast, inosine, uridine, and the nucleobases did not inhibit the influx of 40 p.M 170U88. NBMPR, dipyridamole, and dilazep, which are potent inhibitors of nucleoside transport, all effectively inhibited the influx of ara-M. However, these agents had no effect on the influx of 170U88.
Partition coefficients. The partition coefficients of ara-M and 170U88 in 1-octanol:0. with trichloroacetic acid revealed that >95% of the cellassociated radioactivity recovered was unchanged ara-M. Ninety-seven and 96% of the radioactivity recovered from extracts of erythrocytes incubated with 0.55 mM [14C]170U88 for 5 s or 10 min, respectively, were associated with unmetabolized 170U88.
DISCUSSION
Like adenine arabinoside (3-5) and guanine arabinoside (17) , ara-M enters human erythrocytes primarily by means of the NBMPR-sensitive nucleoside transporter. Potent inhibition by NBMPR, dilazep, and dipyridamole, as well as marked inhibition by nucleosides, supports this contention. The lack of inhibition by nucleobases indicates that the nucleobase transporter is not involved in the influx of ara-M. The Km value (106 ,uM) obtained for ara-M influx is similar to that reported for adenosine (14, 15) and confirmed in these studies (Fig. 5) . The methoxy substituent at the 6 position of this compound imparts increased lipophilicity to the molecule, which may account for the low, but detectable, rate of nonfacilitated diffusion observed at ara-M concentrations in excess of 2 mM. The partition coefficient of ara-M, determined at 37°C (pH 7) in octanol-water, was 0.23, which is comparable to that of 2'3'-dideoxythymidine (11) . However, the latter enters erythrocytes solely by means of nonfacilitated diffusion, with a rate constant at 37°C of 0.34 pmol/s/ ,uM/10 ,ul of packed cells. Although the methoxy group of ara-M contributes to its lipophilicity, apparently the arabinose sugar moiety imparts good substrate efficiency for the nucleoside transporter. This conclusion is in agreement with the observation that pyrimidine arabinosides were found to be comparable to thymidine in their affinity for the nucleoside transporter (12) . By contrast, it is known that modifications at the 3' position of nucleosides are not well tolerated by the transporter (11, 12, 23 Adenosine was found to be a competitive inhibitor of the influx of ara-M, and conversely, competitive inhibition of adenosine influx by ara-M was observed. The Ki (129 ,uM) for ara-M against adenosine influx was comparable to the Km for ara-M (106 ,uM), further indicating that these two compounds use the same carrier to permeate the erythrocyte membrane.
The influx of ara-M was found to be nonconcentrative, and equilibrium with extracellular permeant was obtained in approximately 20 s at 37°C with a permeant concentration of 10 p.M. High-pressure liquid chromatographic analysis of cell extracts indicated that >95% of the intracellular ara-M was not metabolized during this period of time.
Unlike ara-M, its 2'-O-valerate ester, 170U88, enters human erythrocytes solely by nonfacilitated diffusion. This is evident from the linear dependence of influx on concentration and by the lack of inhibition of 170U88 influx by NBMPR, dilazep, dipyridamole, nucleosides, and nucleobases. These data, taken collectively, suggest that 170U88 permeates the membrane of human erythrocytes by nonfacilitated diffusion. The ability of nucleoside analogs such as 170U88 and 3'-azido-3'-deoxythymidine (23) VOL. 36, 1992 of cells, particularly target cells, since it is known that NBMPR-insensitive and sodium-dependent nucleoside transporters (7-9, 13, 16, 22) , in addition to the NBMPRsensitive nucleoside transporter, exist in other cell types.
